Skip to content
Assyro AI
FDA 483 Database

FDA Form 483s Issued in April 2022

Every published Form FDA 483 issued in April 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

7

Published 483s in April 2022

7

Distinct firms

Form 483s issued in April 2022

  • Kyowa Hakko Bio Co., Ltd.FDA
    FEI
    3007807424
    Record date
    Establishment
    Active Pharmaceutical Ingredient Manufacturer
    Location
    Japan
  • Lynn Oaks Compounding PharmacyFDA
    FEI
    3021028639
    Record date
    Establishment
    Producer of Non Sterile Drug Products
    Location
    California, United States
  • Providence Health and Services Washington Dba Providence Infusion Hospital ServicesFDA
    FEI
    3014577316
    Record date
    Establishment
    Outsourcing Facility
    Location
    Washington, United States
  • New England Life Care, Inc. dba Advanced Compounding SolutionsFDA
    FEI
    3010371376
    Record date
    Establishment
    Outsourcing Facility
    Location
    Massachusetts, United States
  • US Specialty Formulations LLCFDA
    FEI
    3010680515
    Record date
    Establishment
    Outsourcing Facility
    Location
    Pennsylvania, United States
  • Brookfield Medical/Surgical Supply, Inc.FDA
    FEI
    3011430551
    Record date
    Establishment
    Outsourcing Facility
    Location
    Connecticut, United States
  • Nephron Sterile Compounding Center LLCFDA
    FEI
    3011158388
    Record date
    Establishment
    Outsourcing Facility
    Location
    South Carolina, United States

Other months in 2022

Back to the FDA 483 Database